TEL: (+62) 21 5890 1590
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
It should come as no surprise that fat reduction treatments are the most popular non-invasive body treatment in aesthetics. As many as 86% of people are bothered by excess weight on their body, and they’re looking for a solution that can deliver the results they want without the pain, high cost, and downtime typically associated with surgery. The answer? Venus Bliss™. Adding non-invasive lipolysis to your clinic offerings with Venus Bliss™ is a sure way to tap into the lucrative market of fat reduction treatments.
Non-invasive body contouring is the fastest-growing area of cosmetic dermatology today. According to the American Society of Aesthetic Plastic Surgeons, the number of non-invasive fat reduction procedures performed tripled between 2012 to 2017, and this growth shows no sign of slowing. The global non-invasive fat reduction market is expected to expand at a rate of over 15% and be valued at $2.5 billion by 2025.
Results. In terms of results, Venus Bliss™ delivers. One study showed a 24% reduction in fat volume when treating the abdomen and flanks, two stubborn areas for fat retention that are a top priority for patients. Most importantly, patients report treatment satisfaction of more than 90%, and only mild side effects such as slight soreness and minor swelling are seen1.
Safety. The treatment is completely non-invasive, which means the use of this laser lipolysis device avoids complications that often arise, or with invasive procedures such as liposuction. Like all our patented technologies, it is safe for all skin types.
Comfort. With all aesthetic treatments, we’ve seen that comfort is an important factor to patients when considering trying a new treatment. Venus Bliss™ ensures a comfortable experience with its contact cooling system, which regulates temperature and prevents damage to the surface of the skin.
No Downtime. Fat reduction treatments with Venus Bliss™ require no downtime whatsoever. Only lasting 15-30 minutes, the sessions are convenient, quick, and allow patients to return to their regular daily activities immediately.
Venus Bliss™ fat reduction treatments are powered by the latest in diode laser technology, which works by heating the adipose tissue layer to induce lipolysis and start apoptotic processes. (MP)2 applicators emit a 1064 nm wavelength, which effectively passes through the skin and is absorbed by the adipose tissue layer where it heats the fat cells. The targeted fat cells release stored triglycerides, causing some to shrink and others to destruct completely. Leftover cellular debris is processed out by the body through the lymphatic system. Here is an in-depth look at the core technologies powering the device:
Venus Concept is known for our easy-to-use, non-invasive technologies that serve customers in a safe and effective manner. Our innovative products help you reach a wider patient base all while providing services that are in line with the needs of the modern aesthetic customer. Backed by clinically validated effectiveness, Venus Bliss™ is a comprehensive solution that allows you to deliver results for your patients and with no per-treatment usage fees for you as the provider. With the increasing demand for non-invasive fat reduction treatments, Venus Bliss™ offers a high ROI and helps you to grow your practice by offering patients the most innovative technology that is clinically proven to meet their aesthetic needs.
To bring this state-of-the-art aesthetic device to your practice, speak to one of our experts today.
DISCLAIMER:
*The (MP)2 applicator is licensed by Health Canada and CE marked for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.
REFERENCES:
1. Mikaela Kislevitz, MD, BSN, RN, Christine Wamsley, BA, Alison Kang, MD, Suzanne Kilmer, MD, John Hoopman, CMLSO, Jennifer Barillas, BS, Jeffrey M Kenkel, MD, Clinical Evaluation of the Safety and Efficacy of a 1060-nm Diode Laser for Non-Invasive Fat Reduction of the Abdomen, Aesthetic Surgery Journal, Volume 41, Issue 10, October 2021, Pages 1155–1165, https://doi.org/10.1093/asj/sjaa418
For more information call: (+62 21) 5890 1590 // info.id@venusconcept.com // Ruko Business Park Kebon Jeruk Blok B11 Jl. Meruya Ilir Raya No. 88 Kel. Meruya Utara, Kec. Kembangan West Jakarta 11620
REGULATORY CLEARANCES [ More ]
All devices have received Indonesian Health Ministry Approval for sale and use in Indonesia. (Izin Edar Alat Kesehatan)
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Viva™ is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for the treatment of moderate to severe wrinkles and rhytides in Fitzpatrick skin types I-IV.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of stretch marks at the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2018 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here